Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hjorth-Hansen%2C+H.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hjorth-Hansen%2C+H.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2020
Mark European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A. ; Baccarani, M. ; Silver, R. T. ; Schiffer, C. ; Apperley, J. F. ; Cervantes, F. ; Clark, R. E. ; Cortes, J. E. ; Deininger, M. W. and Guilhot, F. , et al. (2020) In Leukemia 34(4). p.966-984
- Contribution to journal › Scientific review
2017
Mark Chronic myeloid leukaemia : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hochhaus, A ; Saussele, Susanne ; Rosti, G ; Mahon, Francois-Xavier ; Janssen, J. J.W.M. ; Hjorth-Hansen, H. ; Richter, J. ^LU and Buske, Christian (2017) In Annals of Oncology 28. p.41-51
- Contribution to journal › Article
Mark Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Ilander, M. ; Olsson-Strömberg, U. ; Schlums, H. ; Guilhot, J. ; Brück, O. ; Lähteenmäki, H. ; Kasanen, T. ; Koskenvesa, P. ; Söderlund, S. and Höglund, M. ^LU , et al. (2017) In Leukemia 31(5). p.1108-1116
- Contribution to journal › Article
2016
Mark Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Hjorth-Hansen, H. ; Stentoft, J. ; Richter, J. ; Koskenvesa, P. ; Höglund, M. ; Dreimane, A. ; Porkka, K. ; Gedde-Dahl, T. ; Gjertsen, B. T. and Gruber, F. X. , et al. (2016) In Leukemia 30(9). p.1853-1860
- Contribution to journal › Article
2013
Mark Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Mustjoki, S. ; Richter, Johan ^LU ; Barbany, G. ; Ehrencrona, Hans ^LU ; Fioretos, Thoas ^LU ; Gedde-Dahl, T. ; Gjertsen, B. T. ; Hovland, R. ; Hernesniemi, S. and Josefsen, D. , et al. (2013) In Leukemia 27(7). p.1520-1526
- Contribution to journal › Article
2009
Mark Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
Mustjoki, S. ; Ekblom, Marja ^LU ; Arstila, T. P. ; Dybedal, I. ; Epling-Burnette, P. K. ; Guilhot, F. ; Hjorth-Hansen, H. ; Hoglund, M. ; Kovanen, P. and Laurinolli, T. , et al. (2009) In Leukemia 23(8). p.1398-1405
- Contribution to journal › Article
2004
Mark Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
Standal, T ; Hjorth-Hansen, H ; Rasmussen, T ; Dahl, IMS ; Lenhoff, Stig ^LU ; Brenne, AT ; Seidel, C ; Baykov, V ; Waage, A and Borset, M , et al. (2004) In Haematologica 89(2). p.174-182
- Contribution to journal › Article

your query:: Remove author: Hjorth-Hansen, H.